» Articles » PMID: 38001869

Reactive Oxygen Species and Strategies for Antioxidant Intervention in Acute Respiratory Distress Syndrome

Overview
Date 2023 Nov 25
PMID 38001869
Authors
Affiliations
Soon will be listed here.
Abstract

Acute respiratory distress syndrome (ARDS) is a life-threatening pulmonary condition characterized by the sudden onset of respiratory failure, pulmonary edema, dysfunction of endothelial and epithelial barriers, and the activation of inflammatory cascades. Despite the increasing number of deaths attributed to ARDS, a comprehensive therapeutic approach for managing patients with ARDS remains elusive. To elucidate the pathological mechanisms underlying ARDS, numerous studies have employed various preclinical models, often utilizing lipopolysaccharide as the ARDS inducer. Accumulating evidence emphasizes the pivotal role of reactive oxygen species (ROS) in the pathophysiology of ARDS. Both preclinical and clinical investigations have asserted the potential of antioxidants in ameliorating ARDS. This review focuses on various sources of ROS, including NADPH oxidase, uncoupled endothelial nitric oxide synthase, cytochrome P450, and xanthine oxidase, and provides a comprehensive overview of their roles in ARDS. Additionally, we discuss the potential of using antioxidants as a strategy for treating ARDS.

Citing Articles

Primed Mesenchymal Stem Cells by IFN-γ and IL-1β Ameliorate Acute Respiratory Distress Syndrome through Enhancing Homing Effect and Immunomodulation.

Kong T, Seo S, Han Y, Seo W, Kim B, Kim J Biomol Ther (Seoul). 2025; 33(2):311-324.

PMID: 39973472 PMC: 11893491. DOI: 10.4062/biomolther.2025.004.


Pathophysiological mechanisms of ARDS: a narrative review from molecular to organ-level perspectives.

Zhou K, Qin Q, Lu J Respir Res. 2025; 26(1):54.

PMID: 39948645 PMC: 11827456. DOI: 10.1186/s12931-025-03137-5.


Intranasal delivery of macrophage cell membrane cloaked biomimetic drug-nanoparticle system attenuates acute lung injury.

Zhao Y, Shen X, Fan Y, Wei N, Ling Z, Yao Y J Tissue Eng. 2024; 15:20417314241287487.

PMID: 39698514 PMC: 11653438. DOI: 10.1177/20417314241287487.


Emerging roles of mechanosensitive ion channels in ventilator induced lung injury: a systematic review.

Liu G, Dong B, Devanarayana S, Chen R, Liu Q Front Immunol. 2024; 15:1479230.

PMID: 39664395 PMC: 11631737. DOI: 10.3389/fimmu.2024.1479230.


Neurodegenerative diseases and catechins: (-)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress.

Li S, Wang Z, Liu G, Chen M Front Nutr. 2024; 11:1425839.

PMID: 39149548 PMC: 11326534. DOI: 10.3389/fnut.2024.1425839.


References
1.
Tomashefski Jr J . Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med. 2000; 21(3):435-66. DOI: 10.1016/s0272-5231(05)70158-1. View

2.
Petronilho F, Florentino D, Silvestre F, Danielski L, Nascimento D, Vieira A . Ebselen Attenuates Lung Injury in Experimental Model of Carrageenan-Induced Pleurisy in Rats. Inflammation. 2015; 38(4):1394-400. DOI: 10.1007/s10753-015-0113-5. View

3.
OMahony D, Glavan B, Holden T, Fong C, Black R, Rona G . Inflammation and immune-related candidate gene associations with acute lung injury susceptibility and severity: a validation study. PLoS One. 2012; 7(12):e51104. PMC: 3522667. DOI: 10.1371/journal.pone.0051104. View

4.
Deshmukh P, Unni S, Krishnappa G, Padmanabhan B . The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases. Biophys Rev. 2017; 9(1):41-56. PMC: 5425799. DOI: 10.1007/s12551-016-0244-4. View

5.
Lapinsky S, Mehta S . Bench-to-bedside review: Recruitment and recruiting maneuvers. Crit Care. 2005; 9(1):60-5. PMC: 1065091. DOI: 10.1186/cc2934. View